Skip to main content
Clinical Trials/JPRN-UMIN000006208
JPRN-UMIN000006208
Recruiting
Phase 1

Phase I/II trial of neoadjuvant chemotherapy with UFT/Leucovorin and Irinotecan plus radiation in patients with locally advanced rectal cancer. - Phase I/II trial of neoadjuvant chemotherapy with UFT/Leucovorin and Irinotecan plus radiation in patients with locally advanced rectal cancer.

The University of Tokyo Hospital. Department of surgical oncology.0 sites39 target enrollmentAugust 22, 2011

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
ocally advanced rectal cancer with preoperative diagnosis of T3-4 and N0-3.
Sponsor
The University of Tokyo Hospital. Department of surgical oncology.
Enrollment
39
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 22, 2011
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
The University of Tokyo Hospital. Department of surgical oncology.

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.Allergic to a drug 2\.Contraindications to UFT, Leucovorin and Irinotecan 3\.Active infection 4\.UGT1A: \*6/\*6, \*28/\*28 and \*6/\*28 5\.Severe complications such as ileus, interstitial pneumonia, DM, heart failure, lung failure and liver failure 6\.Pregnant or planning to get pregnant.

Outcomes

Primary Outcomes

Not specified

Similar Trials